A61K 38/2006
Il-1
Official title: {il-1}
A61K38/2006 (Il-1) appears on 288 US grants and 451 published applications in this corpus.
Search patents in A61K- Granted patents
- 288
- Published applications
- 451
- Assignees
- 276
- Inventors
- 769
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 3 | 0 |
| 1991 | 1 | 0 |
| 1992 | 9 | 0 |
| 1993 | 15 | 0 |
| 1994 | 8 | 0 |
| 1995 | 4 | 0 |
| 1996 | 4 | 0 |
| 1997 | 5 | 0 |
| 1998 | 7 | 0 |
| 1999 | 4 | 0 |
| 2000 | 5 | 0 |
| 2001 | 1 | 2 |
| 2002 | 6 | 10 |
| 2003 | 7 | 8 |
| 2004 | 3 | 8 |
| 2005 | 3 | 11 |
| 2006 | 3 | 14 |
| 2007 | 2 | 7 |
| 2008 | 2 | 11 |
| 2009 | 8 | 16 |
| 2010 | 4 | 14 |
| 2011 | 3 | 20 |
| 2012 | 5 | 15 |
| 2013 | 4 | 12 |
| 2014 | 8 | 36 |
| 2015 | 13 | 24 |
| 2016 | 14 | 20 |
| 2017 | 30 | 16 |
| 2018 | 15 | 16 |
| 2019 | 13 | 24 |
| 2020 | 9 | 19 |
| 2021 | 18 | 31 |
| 2022 | 11 | 38 |
| 2023 | 4 | 28 |
| 2024 | 16 | 21 |
| 2025 | 8 | 19 |
| 2026 | 9 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for treating Covid-1916 Jun 2026US 12,653,806 B2Medstar Health, Inc.
- Multi-targeted, tunable, sustained delivery of payloads to charged avascular tissues16 Jun 2026US 12,653,899 B2Massachusetts Institute of Technology
- CXCL8 inhibitors for use in the treatment of COVID-1926 May 2026US 12,636,268 B2Dompé Farmaceutici S.P.A.
- Compositions and methods for metal containing formulations capable of modulating immune response12 May 2026US 12,622,922 B2The Regents of the University of Michigan
- Methods for the production of pharmaceutical agents21 Apr 2026US 12,605,405 B2Orthogen AG
- Micronized compositions for wound healing prepared from human umbilical cord tissue and intact amnion-chorion tissue having an intact intermediate spongy layer positioned there between1 Oct 2026US 2026/0294982 A1Biostem Technologies, Inc.
- Methods and Compositions for Treating Osteoarthritis10 Sep 2026US 2026/0263499 A1Genascence Corporation
- Methods and compositions for treating conditions using recombinant self-complementary adeno-associated virus10 Sep 2026US 2026/0263561 A1University of Florida Research Foundation, Inc.
- Activatable Drug Conjugates and Therapeutic Applications Thereof13 Aug 2026US 2026/0232817 A1California Institute of Technology
- Fusokines involving cytokines with strongly reduced receptor binding affinities18 Jun 2026US 2026/0167687 A1Centre Hospitalier Regional Universitaire De Montpellier
Most cited
By later US patents
- Lineage-directed induction of human mesenchymal stem cell differentiation264US 5,736,396 ACase Western Reserve University · 1998
- Lineage-directed induction of human mesenchymal stem cell differentiation212US 5,942,225 ACase Western Reserve University · 1999
- Upregulation of endogenous prostaglandins to lower intraocular pressure109US 6,376,541 B1Alcon Manufacturing, Ltd. · 2002
- Cancer treatment by combination therapy109US 7,510,830 B2Cancer Research Technology Limited · 2009
- Method and agents for inhibiting protein aging104US 4,758,583 AThe Rockefeller University · 1988